Lymphangioleiomyomatosis

This article relies excessively on references to primary sources. Please improve this article by adding secondary or tertiary sources. Find sources: "Lymphangioleiomyomatosis" – news · newspapers · books · scholar · JSTOR (January 2017) (Learn how and when to remove this message)

Lymphangioleiomyomatosis (LAM)
Other names	lymphangiomyomatosis, LAM
Figure A shows the location of the lungs and airways in the body. The inset image shows a cross-section of a healthy lung. Figure B shows a view of the lungs with LAM and a collapsed lung (pneumothorax). The inset image shows a cross-section of a lung with LAM.
Specialty	Pulmonology

Lymphangioleiomyomatosis (LAM) is a rare, progressive and systemic disease that typically results in cystic lung destruction. It predominantly affects women, especially during childbearing years.^[1] The term sporadic LAM is used for patients with LAM not associated with tuberous sclerosis complex (TSC), while TSC-LAM refers to LAM that is associated with TSC.^[2]